These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A trial of topical acyclovir in genital herpes simplex virus infections. Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052 [TBL] [Abstract][Full Text] [Related]
4. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350 [TBL] [Abstract][Full Text] [Related]
5. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298 [TBL] [Abstract][Full Text] [Related]
6. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923 [TBL] [Abstract][Full Text] [Related]
7. Intravenous acyclovir for the treatment of primary genital herpes. Corey L; Fife KH; Benedetti JK; Winter CA; Fahnlander A; Connor JD; Hintz MA; Holmes KK Ann Intern Med; 1983 Jun; 98(6):914-21. PubMed ID: 6305244 [TBL] [Abstract][Full Text] [Related]
8. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297 [TBL] [Abstract][Full Text] [Related]
9. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Corey L; Benedetti JK; Critchlow CW; Remington MR; Winter CA; Fahnlander AL; Smith K; Salter DL; Keeney RE; Davis LG; Hintz MA; Connor JD; Holmes KK Am J Med; 1982 Jul; 73(1A):326-34. PubMed ID: 7048919 [TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210 [TBL] [Abstract][Full Text] [Related]
12. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus. Bryson YJ J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052 [TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086 [TBL] [Abstract][Full Text] [Related]
14. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. Reichman RC; Badger GJ; Guinan ME; Nahmias AJ; Keeney RE; Davis LG; Ashikaga T; Dolin R J Infect Dis; 1983 Feb; 147(2):336-40. PubMed ID: 6298318 [TBL] [Abstract][Full Text] [Related]